Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$555M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$435M |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$428M |
| 4 |
Accenture
ACN
|
+$402M |
| 5 |
Fortive
FTV
|
+$384M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$535M |
| 2 |
NVIDIA
NVDA
|
+$518M |
| 3 |
Coca-Cola
KO
|
+$488M |
| 4 |
AT&T
T
|
+$474M |
| 5 |
Meta Platforms (Facebook)
META
|
+$461M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.74% |
| 2 | Healthcare | 2.42% |
| 3 | Financials | 2.31% |
| 4 | Consumer Discretionary | 1.76% |
| 5 | Industrials | 1.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
CALL
CRISPR Therapeutics
CRSP
$5.18B
| $30M | 0.01% |
477,900
-22,400
| -4% | -$1.41M |
|
1477
PUT
Teva Pharmaceuticals
TEVA
$42.8B
| $30M | 0.01% |
3,192,500
-2,800
| -0.1% | -$23.4K |
|
1478
Deckers Outdoor
DECK
$12.7B
| $30M | 0.01% |
656,976
-844,506
| -56% | -$41.9M |
|
|
CCMP
1479
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $30M | 0.01% |
161,619
+120,690
| +295% | +$22.3M |
|
1480
Amphenol
APH
$206B
| $29.9M | 0.01% |
794,138
-785,302
| -50% | -$30.4M |
|
|
CYBR
1481
CALL
DELISTED
CyberArk
CYBR
| $29.9M | 0.01% |
177,300
+70,100
| +65% | +$10.6M |
|
1482
PUT
Archer Daniels Midland
ADM
$38.8B
| $29.9M | 0.01% |
331,200
+159,700
| +93% | +$12.4M |
|
|
HES
1483
CALL
DELISTED
Hess
HES
| $29.9M | 0.01% |
279,000
-101,500
| -27% | -$9.63M |
|
1484
CALL
ResMed
RMD
$32.6B
| $29.9M | 0.01% |
123,100
+93,100
| +310% | +$22.5M |
|
1485
PBF Energy
PBF
$8.52B
| $29.8M | 0.01% |
1,221,818
+691,349
| +130% | +$13.1M |
|
1486
SLB Ltd
SLB
$79.8B
| $29.8M | 0.01% |
+720,280
| New | +$28.2M |
|
1487
iShares Silver Trust
SLV
$31.5B
| $29.8M | 0.01% |
1,300,455
+909,031
| +232% | +$20.2M |
|
1488
CALL
Bausch Health
BHC
$2.43B
| $29.7M | 0.01% |
1,298,800
+440,200
| +51% | +$10.8M |
|
1489
CALL
Kimberly-Clark
KMB
$36.7B
| $29.7M | 0.01% |
240,900
-190,300
| -44% | -$25.1M |
|
1490
State Street SPDR S&P Biotech ETF
XBI
$10.3B
| $29.6M | 0.01% |
329,862
+226,639
| +220% | +$20.9M |
|
|
1491
PUT
CRISPR Therapeutics
CRSP
$5.18B
| $29.5M | 0.01% |
470,500
+105,900
| +29% | +$6.65M |
|
1492
PUT
Nu Holdings
NU
$73.6B
| $29.5M | 0.01% |
3,822,600
+3,769,200
| +7,058% | +$30.2M |
|
1493
CALL
Pool Corp
POOL
$7.08B
| $29.4M | 0.01% |
69,600
+10,800
| +18% | +$5.04M |
|
1494
PUT
Futu Holdings
FUTU
$14.8B
| $29.4M | 0.01% |
903,600
-371,500
| -29% | -$14.9M |
|
|
VAQC
1495
DELISTED
Vector Acquisition Corporation II Class A Ordinary Shares
VAQC
| $29.4M | 0.01% |
3,015,132
+100,684
| +3% | +$981K |
|
1496
American Electric Power
AEP
$68.4B
| $29.4M | 0.01% |
294,333
-1,303,447
| -82% | -$119M |
|
1497
CALL
AerCap
AER
$24B
| $29.3M | 0.01% |
581,800
+122,600
| +27% | +$7.35M |
|
1498
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $29.2M | 0.01% |
368,002
-887,740
| -71% | -$69.7M |
|
1499
PUT
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $29.2M | 0.01% |
883,100
+400,500
| +83% | +$14.4M |
|
1500
SAP
SAP
$240B
| $29.2M | 0.01% |
263,277
+142,111
| +117% | +$17.3M |
|
Similar funds
Ken Griffin's Q1 2022 Portfolio in Review
As of Q1 2022, Ken Griffin held 15,382 positions worth $484B, down 1% from $489B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Griffin deployed $23.6B of net new capital in Q1 2022, opening 1,669 new positions and adding to 5,510 existing holdings. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was NVIDIA, an estimated $518M trimmed.
- Ken Griffin's largest Q1 2022 buy was iShares 20+ Year Treasury Bond ETF: 3,151,731 shares worth $416M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $555M increase.
- Ken Griffin's biggest Q1 2022 reduction was NVIDIA, cutting an estimated $518M.
- Ken Griffin fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $535M.
- Ken Griffin's ten largest holdings make up 32% of its $484B portfolio in Q1 2022.
- Ken Griffin opened 1,669 new positions and closed 1,922 in Q1 2022.
- Ken Griffin's portfolio value fell 1% quarter-over-quarter to $484B.
Based on Citadel Advisors's 13F filing for Q1 2022, filed 16 May 2022.